Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-881-7 | CAS number: 10411-92-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LLNA, Sensitising (Read-across, OECD 429, GLP, K, rel. 1)
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 2012-09-04 to 2012-09-18
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Study performed according to OECD test guideline No. 429 and in compliance with GLP.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- UK GLP standards
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories UK Ltd., Oxon, UK
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 15-23 g
- Housing: Individually housed, in suspended solid-floor polypropylene cages furnished with softwood woodflakes
- Diet: : ad libitum (2014C Teklad Global Rodent diet supplied by Harlan Laboratories UK Ltd., Oxon, UK).
- Water: mains tap water ad libitum.
The diet and water are routinely analysed and are considered not to contain any contaminants that could reasonably be expected to affect the purpose or integrity of the study.
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-25
- Humidity (%): 30-70
- Air changes (per hr): at least 15
- Photoperiod (hrs dark / hrs light): 12/12 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 100%, 50% and 25%
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS:
- Procedure: The mouse was treated by daily application of 25 µl of the undiluted test item to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The mouse was observed twice daily on Days 1, 2 and 3 and once daily on Days 4, 5 and 6. Local skin irritation was scored daily according to the scale included as Appendix 4. Any clinical signs of toxicity, if present, were also recorded. The bodyweight was recorded on Day 1 (prior to dosing) and on Day 6.
The thickness of each ear was measured using an Oditest micrometer (Dyer, PA), pre-dose and post dose on Day 1, post dose on Days 2 and 3 and on Days 4, 5 and 6. Any changes in the ear thickness were noted. Mean ear thickness changes were calculated between Days 1 to 3 and Days 1 to 6. A mean ear thickness increase of equal to or greater than 25% was considered to indicate excessive irritation and limited
biological relevance to the endpoint of sensitisation.
- Results: No signs of systemic toxicity, visual local skin irritation or excessive irritation indicated by an equal to or greater than 25% increase in mean ear thickness were noted.
Based on this information the undiluted test item and the test item at concentrations of 50% and 25% v/v in acetone/olive oil 4:1 were selected for the main test.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: individual approach, using tritiated (3H)-methyl thymidine, according to the OECD 429 test guideline.
- Additional investigation: measurement of ear thickness. The thickness of each ear was measured using an Oditest micrometer (Dyer, PA), pre-dose and post dose on Day 1, post dose on Days 2 and 3 and on Days 4, 5 and 6. Any changes in the ear thickness were noted. Mean ear thickness changes were calculated between Days 1 to 3 and Days 1 to 6 A mean ear thickness increase of equal to or greater than 25% was considered to indicate excessive irritation and limited biological relevance to the endpoint of sensitisation.
- Criteria used to consider a positive response: The decision process with regard to identification of a positive response will include a SI of ≥ 3, together with consideration of dose-response, and where appropriate, statistical significance. Any test item failing to produce a SI of ≥ 3 at all test concentrations will not be regarded as a skin sensitiser.
TREATMENT PREPARATION AND ADMINISTRATION:
All formulations will be used within two hours of preparation and will be assumed to be stable for this period. The concentration, homogeneity or stability of the formulations was not determined by analysis. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Data was processed to give group mean values for disintegrations per minute and standard deviations where appropriate. Individual and group mean disintegrations per minute values were assessed for dose response relationships by analysis of homogeneity of variance followed by one way analysis of variance (ANOVA). In the event of a significant result from the ANOVA, pairwise comparisons were performed between control and treated groups. For homogenous datasets Dunnett’s Multiple Comparison test was used and for non homogenous datasets Dunnett’s T3 Multiple Comparison Method was used.
- Positive control results:
- A group of five animals was treated with 50 µl (25 µl per ear) of α-Hexylcinnamaldehyde, tech., 85% as a solution in acetone/olive oil 4:1 at a concentration of 25% v/v. A further control group of five animals was treated with acetone/olive oil 4:1 alone. With a SI = 5.76, α-Hexylcinnamaldehyde, tech., 85% was considered to be a sensitiser under the conditions of the test.
- Key result
- Parameter:
- EC3
- Value:
- 81
- Test group / Remarks:
- %
- Key result
- Parameter:
- SI
- Value:
- 1.39
- Test group / Remarks:
- 25%
- Key result
- Parameter:
- SI
- Value:
- 1.98
- Test group / Remarks:
- 50%
- Key result
- Parameter:
- SI
- Value:
- 3.61
- Test group / Remarks:
- 100%
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
0% : mean DPM / animal = 3864.68.
25%: mean DPM / animal = 5383.15.
50%: mean DPM / animal = 7649.61.
100%: mean DPM / animal = 13956.12.
CLINICAL OBSERVATIONS:
There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test. No visual local skin irritation or excessive irritation indicated by an equal to or greater than 25% increase in mean ear thickness were noted at any dose concentration evaluated.
BODY WEIGHTS
Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals over the same period. - Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- Under the test conditions, the test item is classified as a skin sensitizer in the Local Lymph Node Assay Skin Sens. 1B (H317: May cause an allergic skin reaction) according to the Regulation (EC) No. 1272/2008 (CLP) and to the GHS.
- Executive summary:
A study was performed to assess the skin sensitisation potential of the test item in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear. The method was conducted according to the OECD test guideline No 429 and in compliance with GLP.
Following a preliminary screening test in which no clinical signs of toxicity were noted at a test concentration of 100%, this concentration of 100% was selected as the highest dose to be investigated in the main test.
Three groups, each of five animals, were treated with 50 μl (25 μl per ear) of the test item as a solution in acetone/olive oil 4:1 at concentrations of 100%, 50% or 25% v/v for 3 consecutive days. A further group of five animals was treated with acetone/olive oil 4:1 alone. The animals were allowed to rest without dosing on days 4 and 5. On day 6, the proliferation of lymphocytes in the lymph node draining the application site was measured by incorporation of 3H-Methyl Thymidine.
The irritant potential of the test item was assessed in parallel by measurement of ear thickness on days 1 to 6.
The Stimulation Index values expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows:
Concentration
Mean dpm/animal
Test / Control Ratio
Result
Vehicle
3864.68
N/A
N/A
25%
5383.15
1.39
Negative
50%
7649.61
1.98
Negative
100%
13956.12
3.61
Positive
Since the data indicated a positive response, the EC3 value (concentration of test item expected to cause a 3 fold increase in 3HTdR incorporation) was calculated and determined to be 81%.
The historical positive control, α-Hexylcinnamaldehyde, gave a SI of 5.76, when tested at 25 % v/v. The test system was therefore considered to be valid.
There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test. No visual local skin irritation or excessive irritation indicated by an equal to or greater than 25% increase in mean ear thickness were noted at any dose concentration evaluated.
Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals over the same period.
Under the test conditions, the test item is classified as a skin sensitizer in the Local Lymph Node Assay Skin Sens. 1B (H317: May cause an allergic skin reaction) according to the Regulation (EC) No. 1272/2008 (CLP) and to the GHS.
This study is considered as acceptable and satisfies the requirement for sensitisation endpoint.
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Further information is included in Iuclid Section 13.
1. HYPOTHESIS FOR THE ANALOGUE APPROACH
This read-across is based on the hypothesis that the source and target substances have similar physico-chemical and toxicological properties because of their structural similarity.
2. SOURCE AND TARGET CHEMICAL(S) (INCLUDING INFORMATION ON PURITY AND IMPURITIES)
The target and source substances both contain the same two isomers, in a different ratio: the source substance is a multi-constituent, while the target substance is defined as a mono-constituent, the second constituent being an impurity.
3. ANALOGUE APPROACH JUSTIFICATION
Based on structural similarity, and on the concentration of cis-isomers (above the generic concentration limits for classification of mixture set by the CLP Regulation) in the test performed on the source substance, it is considered appropriate and scientifically justified to read-across the data from the source to the target substance.
The study design (OECD 429, GLP) is adequate and reliable for the purpose of the prediction based on read-across. The test material used represents the source substance as described in the hypothesis in terms of purity and impurities. The results of the studies are adequate for the purpose of classification and labelling.
Therefore, based on the considerations above, it can be concluded that the result of the In vivo skin sensitisation test conducted with the source substance is highly likely to predict the properties of the target substance and is considered as adequate to fulfil the information requirement of Annex VII, 8.3.
4. DATA MATRIX
Cf. Iuclid Section 13. - Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- data waiving: supporting information
- Positive control results:
- A group of five animals was treated with 50 µl (25 µl per ear) of α-Hexylcinnamaldehyde, tech., 85% as a solution in acetone/olive oil 4:1 at a concentration of 25% v/v. A further control group of five animals was treated with acetone/olive oil 4:1 alone. With a SI = 5.76, α-Hexylcinnamaldehyde, tech., 85% was considered to be a sensitiser under the conditions of the test.
- Key result
- Parameter:
- EC3
- Value:
- 81
- Test group / Remarks:
- %
- Key result
- Parameter:
- SI
- Value:
- 1.39
- Test group / Remarks:
- 25%
- Key result
- Parameter:
- SI
- Value:
- 1.98
- Test group / Remarks:
- 50%
- Key result
- Parameter:
- SI
- Value:
- 3.61
- Test group / Remarks:
- 100%
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
0% : mean DPM / animal = 3864.68.
25%: mean DPM / animal = 5383.15.
50%: mean DPM / animal = 7649.61.
100%: mean DPM / animal = 13956.12.
CLINICAL OBSERVATIONS:
There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test. No visual local skin irritation or excessive irritation indicated by an equal to or greater than 25% increase in mean ear thickness were noted at any dose concentration evaluated.
BODY WEIGHTS
Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals over the same period. - Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- Under the test conditions, the source substance is classified as a skin sensitizer in the Local Lymph Node Assay Skin Sens. 1B (H317: May cause an allergic skin reaction) according to the Regulation (EC) No. 1272/2008 (CLP) and to the GHS. The same conclusion applies to the target substance.
- Executive summary:
A study was performed to assess the skin sensitisation potential of the source substance in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear. The method was conducted according to the OECD test guideline No 429 and in compliance with GLP.
Following a preliminary screening test in which no clinical signs of toxicity were noted at a test concentration of 100%, this concentration of 100% was selected as the highest dose to be investigated in the main test.
Three groups, each of five animals, were treated with 50 μl (25 μl per ear) of the source substance as a solution in acetone/olive oil 4:1 at concentrations of 100%, 50% or 25% v/v for 3 consecutive days. A further group of five animals was treated with acetone/olive oil 4:1 alone. The animals were allowed to rest without dosing on days 4 and 5. On day 6, the proliferation of lymphocytes in the lymph node draining the application site was measured by incorporation of 3H-Methyl Thymidine.
The irritant potential of the source substance was assessed in parallel by measurement of ear thickness on days 1 to 6.
The Stimulation Index values expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group are as follows:
Concentration
Mean dpm/animal
Test / Control Ratio
Result
Vehicle
3864.68
N/A
N/A
25%
5383.15
1.39
Negative
50%
7649.61
1.98
Negative
100%
13956.12
3.61
Positive
Since the data indicated a positive response, the EC3 value (concentration of test item expected to cause a 3 fold increase in 3HTdR incorporation) was calculated and determined to be 81%.
The historical positive control, α-Hexylcinnamaldehyde, gave a SI of 5.76, when tested at 25 % v/v. The test system was therefore considered to be valid.
There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test. No visual local skin irritation or excessive irritation indicated by an equal to or greater than 25% increase in mean ear thickness were noted at any dose concentration evaluated.
Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals over the same period.
Under the test conditions, the source substance is classified as a skin sensitizer in the Local Lymph Node Assay Skin Sens. 1B (H317: May cause an allergic skin reaction) according to the Regulation (EC) No. 1272/2008 (CLP) and to the GHS. The same conclusion applies to the target substance. Read-across justification is attached to Iuclid section 13.
This study is considered as acceptable and satisfies the requirement for sensitisation endpoint.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
No study was available on the target substance, therefore an analogue approach using the source substance, 4-tert-butylcyclohexyl acetate, was followed to conclude on the skin sensitisation potential the target substance (cf. Section 13 for read-across justification).
The key study (Sanders, 2012, rel.1) was conducted on the source substance according to the OECD test guideline No 429 and in compliance with GLP. Following a preliminary screening test in which no clinical signs of toxicity were noted at a test concentration of 100%, this concentration of 100% was selected as the highest dose to be investigated in the main test. Three groups, each of five animals, were treated with 50μl (25μl per ear) of the source substance as a solution in acetone/olive oil 4:1 at concentrations of 100%, 50% or 25% v/v for 3 consecutive days. A further group of five animals was treated with acetone/olive oil 4:1 alone. The animals were allowed to rest without dosing on days 4 and 5. On day 6, the proliferation of lymphocytes in the lymph node draining the application site was measured by incorporation of3H-Methyl Thymidine. The irritant potential of the test item was assessed in parallel by measurement of ear thickness on days 1 to 6. The Stimulation Index values are as follows: 1.39, 1.98 and 3.61 for the concentrations of 25%, 50% and 100%, respectively. Since the data indicated a positive response, the EC3 was calculated and determined to be 81%. The historical positive control,α-Hexylcinnamaldehyde, gave a SI of 5.76, when tested at 25 % v/v. The test system was therefore considered to be valid. There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test. No visual local skin irritation or excessive irritation indicated by an equal to or greater than 25% increase in mean ear thickness were noted at any dose concentration evaluated. Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals over the same period.
Under the test conditions, the source substance is classified as a skin sensitizer in the Local Lymph Node Assay. The same conclusion applies to the target substance.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Harmonised classification:
The substance has no harmonised classification according to the Regulation (EC) No. 1272/2008 (CLP)
Self classification:
Based on the available information additional self-classification is proposed Skin Sens. 1B (H317: May cause an allergic skin reaction) according to the CLP and the GHS.
No information is available regarding respiratory sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.